Testing effectiveness (Phase 2)Looking for participantsNCT06472388
What this trial is testing
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Who this might be right for
Neuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more
AC Camargo Cancer Center 100